Amoxycillin + Clavulanic Acid in pharma franchise in India

Amoxycillin + Clavulanic Acid in PCD pharma franchise at minimum prices

Top pharma company in India for Amoxycillin + Clavulanic Acid in t

Your Opportunity: Amoxycillin + Clavulanic Acid Tablets for PCD Pharma Franchise

The Assurance of Quality: Manufactured by AKUMS
Why Moxyplit CV 625 (Amoxicillin & Clavulanic Acid) is a Bestselling Product

Home/Products /amoxycillin-500mg-clavulanic-acid-125mg-tablet

About the Product

Description


Moxyplit CV 625 Tablet being an essential product for any successful PCD pharma franchise or B2B business in India is a potent antibiotic combination containing Amoxycillin and Clavulanic Acid. 

As a pharma distributor, you need products that not only guarantee quality but also promise high market acceptance and profitability. Our Moxyplit Cv 625 is manufectured by the India's one of the top class manufecturer AKUMS.

At Cafoli Lifecare, we are committed to helping our partners succeed. We offer this premium, best quality medicine at cheap prices for reselling, ensuring you can achieve excellent profit margins. Our transparent pricing and reliable supply chain guarantee that you can serve your market effectively without compromising on quality. Partner with us to add this bestselling antibiotic to your portfolio and grow your wholesale pharma business with confidence.

Amoxycillin is a broad-spectrum penicillin-class antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death. Clavulanic Acid, a beta-lactamase inhibitor, protects Amoxycillin from degradation by beta-lactamase enzymes produced by resistant bacteria. This combination allows for effective treatment against a wide range of bacterial infections, including those caused by beta-lactamase-producing organisms.


Moxyplit CV 625 Tablet is used to treat a variety of infections such as respiratory tract infections (including pneumonia and bronchitis), urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. It is particularly useful in treating infections that are resistant to other antibiotics due to the action of Clavulanic Acid.

Common side effects may include nausea, diarrhea, vomiting, mild rashes, fungal infections (in areas like the mouth or skin folds), and vaginitis.

"Moxyplit CV 625 Tablet treats bacterial infections in the lungs, ear, nasal sinuses, urinary tract, skin, and soft tissues."

Information regarding the use of Moxyplit CV 625 Tablet during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place, away from direct light. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Amoxycillin 500mg + Clavulanic Acid 125mg Tablet in the PCD pharma franchise market?

This antibiotic combination tablet has strong demand in the anti-infective segment, making it a high-moving product for medical distributors, wholesalers, and pharma franchise partners focusing on general medicine and infection care portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for treatment of respiratory tract infections, sinus infections, urinary tract infections, dental infections, skin infections, and other bacterial infections. Amoxycillin helps eliminate bacteria, while Clavulanic Acid enhances antibiotic effectiveness by overcoming bacterial resistance, strengthening a reliable antibiotic product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this antibiotic combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong physician prescription demand, fast-moving anti-infective category, high seasonal infection sales, reliable supply chain support, and good margins when partnering for this antibiotic product.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, and wholesalers interested in this antibiotic combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.